Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

SenesTech Inc. (NASDAQ: SNES) Posts Strong 44% YOY Revenue Growth for Q3 2023; Looks to Accelerate This Growth with New Product Launch

SenesTech (NASDAQ: SNES), an animal fertility control innovator and the inventor of the only EPA-registered contraceptive for male and female rats, announced its financial results for the third quarter of the 2023 financial year (“Q3, 2023”) on November 9, 2023. Of note was the 44% year-over-year (“YOY”) growth in revenue, primarily attributed to the company’s […]

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) CEO Discusses Recent Hack of China’s Largest Financial Institution, How Sekur Suite of Services Is Designed to Help

New to the Street TV, a leading financial and business news show, recently sat down with Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) CEO Alain Ghiai to discuss the recent cyberattack on one of China’s largest financial institutions. The Weekly Hack segment brings Mr. Ghiai, TV co-host, and multimedia journalist Ana Berry to […]

Podcast: Jewelry Maker GEMXX Corp. (GEMZ) Enjoys Rapid Growth Thanks to Gold Interest, Focus on Vertical Mine-to-Market Integration

The World Gold Council (“WGC”) recently reported that global gold demand slipped in year-over-year purchase totals from last year’s Q3 record highs, but central bank consumption continues at a “historic pace” and when over-the-counter (“OTC”) purchases plus stock flows are added into the equation, demand was actually up 6 percent over the corresponding 2022 period, […]

PaxMedica Inc. (NASDAQ: PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced the completion of a type-B meeting with the Food and Drug Administration. During the live meeting, the company discussed the positive […]

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advances Solution to Chinese Controls on REE Supply Chain

China’s recently announced controls on reporting exports of rare earth metallic elements (“REEs”) used strategically for permanent magnets in computerized products is the latest salvo in the ongoing trade war between the large Asian nation and the United States, prompting further emphasis on the need for Western independence from China-based supply chains. Strategic metals enterprise […]

Empowering Pharma and Biotech Professionals: DGE Explores Strategies to Incorporate Patient Voice Across the Commercial Product Lifecycle, Philadelphia, January 25-26, 2024

Professionals working in the pharma, medical device, and biotechnology companies, are invited to attend the DGE event, Incorporate Patient Voice Across the Commercial Product Lifecycle being held in Philadelphia on January 25-26, 2024. A live-streaming option for the event is also available. The event is organized by Dynamic Global Events (“DGE”), a leading life science […]

Discovering New Golf Friends and Games Locally Has Never Been Easier Thanks to GolfLync Inc.

GolfLync, the pioneering golf social networking platform, is revolutionizing golf networking. GolfLync’s focus is on connecting like-minded players over their shared love for golf. New advanced filtering algorithms empower users to match with new players, find local friends, and discover new Virtual Golf Clubs (“VGC”) locally and while traveling. Now finding the perfect match is […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Results in Ongoing GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced additional positive interim results from its ongoing human pilot study that seeks to provide an early-stage indication of whether DehydraTECH(TM) processing could improve oral drug delivery characteristics of the GLP-1 drug semaglutide. The study, which focused on Rybelsus(R), a commercially available semaglutide […]

PaxMedica Inc. (NASDAQ: PXMD) Closes Public Offering of Approximately $7 Million and Continues Pursuing ASD Pipeline

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently reported the closing of its public offering. PaxMedica’s total gross proceeds from the offering, before deducting the placement agent’s fees and other […]

 

From Our Blog

Forward Industries Inc. (NASDAQ: FWDI) Announces Q2 2026 Financial and Operational Results

May 20, 2026

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently announced financial and operating results for fiscal Q2 2026, which ended March 31, 2026 (https://ibn.fm/Gii28). According to the Chairman of Forward Industries, Kyle Samani, the second fiscal quarter for Forward was “defined by disciplined execution across the business — sharpening our cost structure, strengthening our balance […]

Rotate your device 90° to view site.